Other drugs are being studied for their promise in preventing breast cancer, including a Vitamin A-derivative called fenretinide and the antiosteoporosis drug raloxifene, sold by Eli Lilly lly (nyse: lly - news - people) under the brand name Evista.
FORBES: Old Breast Cancer Drug Brings in New Money